Sympatient

Series-A
sympatient.com Biotech & Healthcare
Total Funding $9M
Latest Round $7M Series-A
Last Announced Oct 3, 2022
Investors Undisclosed
Decision Makers 6 Available

About Sympatient

Sympatient entwickelt PsyOS®, das Betriebssystem für moderne Psychotherapie. Es verbindet Zugang, Versorgung, Praxisbetrieb und Daten.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website sympatient.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @sympatient (100 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $7,000,000 · Series-A

    startupintros.com

  2. Capital Raise

    Raised $2,000,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Sympatient.

Funding History

2 Rounds
Series-A equity · Oct 3, 2022
Seed equity · May 1, 2020

Founders & Leadership

4

Benedikt Reinke

Co-Founder & Geschäftsführer Operations

Work email & phone locked Unlock →

Christian Angern

Co-Founder & Geschäftsführer Wachstum und Marktstrategie

Work email & phone locked Unlock →

Jan-Niklas Rösch

Co-Founder & Chief Technology Officer

Work email & phone locked Unlock →

Julian Angern

Co-Founder & Geschäftsführer Produkt

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts